On July 25, 2023, the Board of Directors of Homology Medicines, Inc. approved a reduction in the Company?s current workforce by approximately 80 employees. The decision was based on cost-reduction initiatives intended to reduce the Company?s ongoing operating expenses and maximize shareholder value as the Company plans to pursue strategic options.